139 related articles for article (PubMed ID: 10052531)
1. No effect of vitamin K1 supplementation on biochemical bone markers in haemodialysis patients.
Reichel H
Nephrol Dial Transplant; 1999 Jan; 14(1):249-50. PubMed ID: 10052531
[No Abstract] [Full Text] [Related]
2. [Prevention and therapy of regulatory hyperparathyroidism in kidney patients].
Koall W; Mampel E; Hintner I; Kokot F
Z Gesamte Inn Med; 1982 Apr; 37(7):197-201. PubMed ID: 7048771
[No Abstract] [Full Text] [Related]
3. Biochemical markers of mineral bone disorder in South African patients on maintenance haemodialysis.
Waziri B; Duarte R; Naicker S
Afr Health Sci; 2017 Jun; 17(2):445-452. PubMed ID: 29062340
[TBL] [Abstract][Full Text] [Related]
4. Severe hyperparathyroidism in a pre-dialysis chronic kidney disease patient treated with a very low protein diet.
Ohta E; Akazawa M; Noda Y; Mandai S; Naito S; Ohta A; Sohara E; Okado T; Rai T; Uchida S; Sasaki S
J Bone Miner Metab; 2012 Mar; 30(2):238-42. PubMed ID: 21989849
[TBL] [Abstract][Full Text] [Related]
5. Can successful renal transplantation resolve secondary hyper-parathyroidism?
Koyama Y; Miyazato T; Hatano T; Ogawa Y
Transplant Proc; 1996 Jun; 28(3):1644-5. PubMed ID: 8658819
[No Abstract] [Full Text] [Related]
6. Parathyroid gland sonography in relation to markers of bone metabolism in kidney transplant recipients.
Małyszko J; Łebkowska U; Wołczyński S; Małyszko JS; Myśliwiec M
Transplant Proc; 2002 Mar; 34(2):593-5. PubMed ID: 12009635
[No Abstract] [Full Text] [Related]
7. Effect of haemodialysis on markers of bone turnover in children.
Waller S; Ridout D; Rees L
Pediatr Nephrol; 2007 Apr; 22(4):586-92. PubMed ID: 17216258
[TBL] [Abstract][Full Text] [Related]
8. Haemodialysis and tertiary hyperparathyrodism: renal homotransplantation and tubular dysfunction.
Doak PB; North JD
Australas Ann Med; 1969 May; 18(2):138-42. PubMed ID: 4895785
[No Abstract] [Full Text] [Related]
9. [Parathyroidectomy in secondary hyperparathyroidism in chronic uremic patients under dialysis treatment. Development of the surgical strategy].
Zucchi C
Minerva Med; 1985 Mar; 76(9-10):397-401. PubMed ID: 3982697
[No Abstract] [Full Text] [Related]
10. A clinical correlative study of bone densitometric changes in hemodialysis patients with hyperparathyroidism.
Adam B; Arik N; Başoğlu T; Akpolat T; Sahin M; Coşkun C; Kandemir T; Bernay I
Nephron; 1996; 74(2):483-4. PubMed ID: 8893202
[No Abstract] [Full Text] [Related]
11. Serum parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D3 in patients on maintenance haemodialysis.
Rassoul Z; Mousa D; Rehman MA; Abdalla AH; Hawas F; Popovich W; Gaisoum M; al-Sulaiman M; Al-Khader A
Am J Nephrol; 1995; 15(6):507-11. PubMed ID: 8546173
[TBL] [Abstract][Full Text] [Related]
12. [Effect of salmon calcitonin on bone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism].
Matuszkiewicz-Rowińska J; Niemczyk S; Przedlacki J; Puka J; Switalski M; Ostrowski K
Pol Arch Med Wewn; 2004 Jul; 112(1):797-803. PubMed ID: 15526839
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid function after kidney allografting.
Tajima A; Ishikawa A; Ohta N; Suzuki K; Kawabe K; Aso Y
Transplant Proc; 1996 Jun; 28(3):1629-30. PubMed ID: 8658814
[No Abstract] [Full Text] [Related]
14. Serum parathyroid hormone concentration in chronic renal failure patients on maintenance haemodialysis.
Wills MR; Fairney A; Varghese Z; Tatler GL; Baillod RA; Moorhead JF
Clin Chim Acta; 1974 Nov; 57(1):83-9. PubMed ID: 4430145
[No Abstract] [Full Text] [Related]
15. [Treatment of secondary hyperparathyroidism resistant to conventional therapy and tertiary hyperparathyroidism with Cinacalcet: an efficiency strategy].
Jean G; Vanel T; Terrat JC; Hurot JM; Lorriaux C; Mayor B; Deleaval P; Vovan C; Chazot C
Nephrol Ther; 2010 Apr; 6(2):105-10. PubMed ID: 20185380
[TBL] [Abstract][Full Text] [Related]
16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
17. Cross-sectional analysis of abnormalities of mineral homeostasis, vitamin D and parathyroid hormone in a cohort of pre-dialysis patients. The chronic renal impairment in Birmingham (CRIB) study.
Zehnder D; Landray MJ; Wheeler DC; Fraser W; Blackwell L; Nuttall S; Hughes SV; Townend J; Ferro C; Baigent C; Hewison M
Nephron Clin Pract; 2007; 107(3):c109-16. PubMed ID: 17890873
[TBL] [Abstract][Full Text] [Related]
18. Bone disease in renal failure. Clinical and histomorphometric studies.
Nilsson P
Scand J Urol Nephrol Suppl; 1984; 84():1-68. PubMed ID: 6393322
[TBL] [Abstract][Full Text] [Related]
19. Low-calcium dialysate worsens secondary hyperparathyroidism.
Argilés A; Mion CM
J Am Soc Nephrol; 1996 Apr; 7(4):635-6. PubMed ID: 8724901
[No Abstract] [Full Text] [Related]
20. Maxillary brown tumor of secondary hyperparathyroidism in a hemodialysis patient.
Weiss RR; Schoeneman MJ; Primack W; Rozycki D; Bennett B; Greifer I
JAMA; 1980 May; 243(19):1929-30. PubMed ID: 7365977
[No Abstract] [Full Text] [Related]
[Next] [New Search]
